nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—SLCO1A2—Prednisolone—allergic rhinitis	0.0713	0.104	CbGbCtD
Naloxone—SLCO1A2—Hydrocortisone—allergic rhinitis	0.0676	0.0982	CbGbCtD
Naloxone—ABCB1—Desloratadine—allergic rhinitis	0.0572	0.083	CbGbCtD
Naloxone—CYP2C8—Loratadine—allergic rhinitis	0.0485	0.0705	CbGbCtD
Naloxone—CYP2C8—Montelukast—allergic rhinitis	0.0485	0.0705	CbGbCtD
Naloxone—SLCO1A2—Dexamethasone—allergic rhinitis	0.042	0.061	CbGbCtD
Naloxone—CYP3A4—Flunisolide—allergic rhinitis	0.0343	0.0497	CbGbCtD
Naloxone—ABCB1—Loratadine—allergic rhinitis	0.0328	0.0477	CbGbCtD
Naloxone—CYP3A4—Olopatadine—allergic rhinitis	0.0322	0.0468	CbGbCtD
Naloxone—ABCB1—Methylprednisolone—allergic rhinitis	0.03	0.0436	CbGbCtD
Naloxone—CYP2C8—Hydrocortisone—allergic rhinitis	0.027	0.0392	CbGbCtD
Naloxone—CYP3A4—Loratadine—allergic rhinitis	0.0197	0.0286	CbGbCtD
Naloxone—CYP3A4—Montelukast—allergic rhinitis	0.0197	0.0286	CbGbCtD
Naloxone—ABCB1—Betamethasone—allergic rhinitis	0.0195	0.0284	CbGbCtD
Naloxone—ABCB1—Prednisolone—allergic rhinitis	0.0193	0.028	CbGbCtD
Naloxone—ABCB1—Hydrocortisone—allergic rhinitis	0.0183	0.0265	CbGbCtD
Naloxone—CYP3A4—Methylprednisolone—allergic rhinitis	0.018	0.0261	CbGbCtD
Naloxone—CYP2C8—Dexamethasone—allergic rhinitis	0.0168	0.0244	CbGbCtD
Naloxone—CYP3A4—Triamcinolone—allergic rhinitis	0.0136	0.0198	CbGbCtD
Naloxone—CYP3A4—Betamethasone—allergic rhinitis	0.0117	0.017	CbGbCtD
Naloxone—CYP3A4—Prednisolone—allergic rhinitis	0.0115	0.0168	CbGbCtD
Naloxone—ABCB1—Dexamethasone—allergic rhinitis	0.0114	0.0165	CbGbCtD
Naloxone—CYP3A4—Hydrocortisone—allergic rhinitis	0.0109	0.0159	CbGbCtD
Naloxone—CYP3A4—Dexamethasone—allergic rhinitis	0.0068	0.00988	CbGbCtD
Naloxone—TLR4—eye—allergic rhinitis	0.00595	0.176	CbGeAlD
Naloxone—CREB1—exocrine gland—allergic rhinitis	0.00551	0.163	CbGeAlD
Naloxone—TLR4—lung—allergic rhinitis	0.00346	0.103	CbGeAlD
Naloxone—CREB1—respiratory system—allergic rhinitis	0.00287	0.085	CbGeAlD
Naloxone—CREB1—eye—allergic rhinitis	0.00262	0.0777	CbGeAlD
Naloxone—CREB1—epithelium—allergic rhinitis	0.0024	0.071	CbGeAlD
Naloxone—CREB1—bronchus—allergic rhinitis	0.00236	0.07	CbGeAlD
Naloxone—CREB1—skin of body—allergic rhinitis	0.00228	0.0676	CbGeAlD
Naloxone—CREB1—lung—allergic rhinitis	0.00152	0.0451	CbGeAlD
Naloxone—Mental disorder—Desloratadine—allergic rhinitis	0.00128	0.00673	CcSEcCtD
Naloxone—Nervousness—Cyproheptadine—allergic rhinitis	0.00128	0.00668	CcSEcCtD
Naloxone—Tremor—Cyproheptadine—allergic rhinitis	0.00123	0.00644	CcSEcCtD
Naloxone—Irritability—Cetirizine—allergic rhinitis	0.00123	0.00643	CcSEcCtD
Naloxone—Agitation—Cyproheptadine—allergic rhinitis	0.00121	0.00632	CcSEcCtD
Naloxone—Irritability—Flunisolide—allergic rhinitis	0.00121	0.00632	CcSEcCtD
Naloxone—Agitation—Desloratadine—allergic rhinitis	0.00117	0.00614	CcSEcCtD
Naloxone—Nasopharyngitis—Cetirizine—allergic rhinitis	0.00115	0.00602	CcSEcCtD
Naloxone—Convulsion—Cyproheptadine—allergic rhinitis	0.00114	0.00596	CcSEcCtD
Naloxone—Nasopharyngitis—Flunisolide—allergic rhinitis	0.00113	0.00592	CcSEcCtD
Naloxone—Mediastinal disorder—Olopatadine—allergic rhinitis	0.00113	0.00592	CcSEcCtD
Naloxone—ESR1—respiratory system—allergic rhinitis	0.00113	0.0335	CbGeAlD
Naloxone—Convulsion—Desloratadine—allergic rhinitis	0.00111	0.00579	CcSEcCtD
Naloxone—Chills—Dimenhydrinate—allergic rhinitis	0.0011	0.00577	CcSEcCtD
Naloxone—Chills—Diphenhydramine—allergic rhinitis	0.0011	0.00577	CcSEcCtD
Naloxone—Depression—Loratadine—allergic rhinitis	0.00105	0.0055	CcSEcCtD
Naloxone—Tension—Dimenhydrinate—allergic rhinitis	0.00105	0.00549	CcSEcCtD
Naloxone—Tension—Diphenhydramine—allergic rhinitis	0.00105	0.00549	CcSEcCtD
Naloxone—Tachycardia—Cyproheptadine—allergic rhinitis	0.00105	0.00548	CcSEcCtD
Naloxone—Nervousness—Dimenhydrinate—allergic rhinitis	0.00104	0.00543	CcSEcCtD
Naloxone—Nervousness—Diphenhydramine—allergic rhinitis	0.00104	0.00543	CcSEcCtD
Naloxone—Hyperhidrosis—Cyproheptadine—allergic rhinitis	0.00104	0.00543	CcSEcCtD
Naloxone—Irritability—Montelukast—allergic rhinitis	0.00103	0.00539	CcSEcCtD
Naloxone—Nervous system disorder—Desloratadine—allergic rhinitis	0.00102	0.00535	CcSEcCtD
Naloxone—Tachycardia—Desloratadine—allergic rhinitis	0.00102	0.00533	CcSEcCtD
Naloxone—Tremor—Diphenhydramine—allergic rhinitis	0.001	0.00524	CcSEcCtD
Naloxone—Tremor—Dimenhydrinate—allergic rhinitis	0.001	0.00524	CcSEcCtD
Naloxone—Agitation—Diphenhydramine—allergic rhinitis	0.000981	0.00514	CcSEcCtD
Naloxone—Agitation—Dimenhydrinate—allergic rhinitis	0.000981	0.00514	CcSEcCtD
Naloxone—Nasopharyngitis—Montelukast—allergic rhinitis	0.000963	0.00505	CcSEcCtD
Naloxone—Paraesthesia—Cyproheptadine—allergic rhinitis	0.000962	0.00504	CcSEcCtD
Naloxone—ESR1—epithelium—allergic rhinitis	0.000943	0.028	CbGeAlD
Naloxone—Sweating—Flunisolide—allergic rhinitis	0.000933	0.00489	CcSEcCtD
Naloxone—Dyspnoea—Desloratadine—allergic rhinitis	0.000929	0.00487	CcSEcCtD
Naloxone—Convulsion—Dimenhydrinate—allergic rhinitis	0.000925	0.00485	CcSEcCtD
Naloxone—Convulsion—Diphenhydramine—allergic rhinitis	0.000925	0.00485	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Olopatadine—allergic rhinitis	0.000922	0.00483	CcSEcCtD
Naloxone—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.000899	0.00471	CcSEcCtD
Naloxone—Hallucination—Cetirizine—allergic rhinitis	0.000884	0.00463	CcSEcCtD
Naloxone—Nervous system disorder—Olopatadine—allergic rhinitis	0.000873	0.00458	CcSEcCtD
Naloxone—Skin disorder—Olopatadine—allergic rhinitis	0.000865	0.00453	CcSEcCtD
Naloxone—Tachycardia—Dimenhydrinate—allergic rhinitis	0.00085	0.00446	CcSEcCtD
Naloxone—Tachycardia—Diphenhydramine—allergic rhinitis	0.00085	0.00446	CcSEcCtD
Naloxone—Hyperhidrosis—Dimenhydrinate—allergic rhinitis	0.000842	0.00441	CcSEcCtD
Naloxone—Hyperhidrosis—Diphenhydramine—allergic rhinitis	0.000842	0.00441	CcSEcCtD
Naloxone—Cardiac disorder—Cetirizine—allergic rhinitis	0.000825	0.00432	CcSEcCtD
Naloxone—Flushing—Cetirizine—allergic rhinitis	0.000825	0.00432	CcSEcCtD
Naloxone—Abdominal pain—Desloratadine—allergic rhinitis	0.000823	0.00431	CcSEcCtD
Naloxone—Body temperature increased—Desloratadine—allergic rhinitis	0.000823	0.00431	CcSEcCtD
Naloxone—Tension—Loratadine—allergic rhinitis	0.000807	0.00423	CcSEcCtD
Naloxone—Nervousness—Loratadine—allergic rhinitis	0.000799	0.00418	CcSEcCtD
Naloxone—Chills—Cetirizine—allergic rhinitis	0.000798	0.00418	CcSEcCtD
Naloxone—Dyspnoea—Olopatadine—allergic rhinitis	0.000794	0.00416	CcSEcCtD
Naloxone—Chills—Flunisolide—allergic rhinitis	0.000784	0.00411	CcSEcCtD
Naloxone—Paraesthesia—Diphenhydramine—allergic rhinitis	0.000782	0.0041	CcSEcCtD
Naloxone—Paraesthesia—Dimenhydrinate—allergic rhinitis	0.000782	0.0041	CcSEcCtD
Naloxone—Mental disorder—Cetirizine—allergic rhinitis	0.000779	0.00408	CcSEcCtD
Naloxone—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.000769	0.00403	CcSEcCtD
Naloxone—Asthenia—Cyproheptadine—allergic rhinitis	0.000769	0.00403	CcSEcCtD
Naloxone—Pain—Olopatadine—allergic rhinitis	0.000761	0.00399	CcSEcCtD
Naloxone—Tension—Cetirizine—allergic rhinitis	0.000759	0.00398	CcSEcCtD
Naloxone—Agitation—Loratadine—allergic rhinitis	0.000756	0.00396	CcSEcCtD
Naloxone—Nervousness—Cetirizine—allergic rhinitis	0.000751	0.00394	CcSEcCtD
Naloxone—Asthenia—Desloratadine—allergic rhinitis	0.000747	0.00392	CcSEcCtD
Naloxone—Hallucination—Montelukast—allergic rhinitis	0.000742	0.00389	CcSEcCtD
Naloxone—Diarrhoea—Cyproheptadine—allergic rhinitis	0.000733	0.00384	CcSEcCtD
Naloxone—Pulmonary oedema—Prednisolone—allergic rhinitis	0.00073	0.00383	CcSEcCtD
Naloxone—Tremor—Cetirizine—allergic rhinitis	0.000725	0.0038	CcSEcCtD
Naloxone—Pulmonary oedema—Hydrocortisone—allergic rhinitis	0.000713	0.00374	CcSEcCtD
Naloxone—Tremor—Flunisolide—allergic rhinitis	0.000713	0.00373	CcSEcCtD
Naloxone—Diarrhoea—Desloratadine—allergic rhinitis	0.000713	0.00373	CcSEcCtD
Naloxone—Agitation—Cetirizine—allergic rhinitis	0.000711	0.00373	CcSEcCtD
Naloxone—Hypertension—Loratadine—allergic rhinitis	0.00071	0.00372	CcSEcCtD
Naloxone—SLCO1A2—lung—allergic rhinitis	0.000706	0.0209	CbGeAlD
Naloxone—Abdominal pain—Olopatadine—allergic rhinitis	0.000704	0.00369	CcSEcCtD
Naloxone—Body temperature increased—Olopatadine—allergic rhinitis	0.000704	0.00369	CcSEcCtD
Naloxone—Agitation—Flunisolide—allergic rhinitis	0.000699	0.00366	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.000695	0.00364	CcSEcCtD
Naloxone—Cardiac disorder—Montelukast—allergic rhinitis	0.000692	0.00362	CcSEcCtD
Naloxone—Vomiting—Cyproheptadine—allergic rhinitis	0.000681	0.00357	CcSEcCtD
Naloxone—OPRM1—IL4-mediated signaling events—IL5—allergic rhinitis	0.000673	0.00774	CbGpPWpGaD
Naloxone—Pulmonary oedema—Triamcinolone—allergic rhinitis	0.000672	0.00352	CcSEcCtD
Naloxone—Mediastinal disorder—Montelukast—allergic rhinitis	0.000672	0.00352	CcSEcCtD
Naloxone—Convulsion—Cetirizine—allergic rhinitis	0.00067	0.00351	CcSEcCtD
Naloxone—Pulmonary oedema—Methylprednisolone—allergic rhinitis	0.00067	0.00351	CcSEcCtD
Naloxone—TLR4—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000669	0.0077	CbGpPWpGaD
Naloxone—Hypertension—Cetirizine—allergic rhinitis	0.000668	0.0035	CcSEcCtD
Naloxone—Vomiting—Desloratadine—allergic rhinitis	0.000662	0.00347	CcSEcCtD
Naloxone—Nervous system disorder—Loratadine—allergic rhinitis	0.000658	0.00345	CcSEcCtD
Naloxone—Hypertension—Flunisolide—allergic rhinitis	0.000657	0.00344	CcSEcCtD
Naloxone—Tachycardia—Loratadine—allergic rhinitis	0.000655	0.00343	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.000654	0.00343	CcSEcCtD
Naloxone—Mental disorder—Montelukast—allergic rhinitis	0.000653	0.00342	CcSEcCtD
Naloxone—Skin disorder—Loratadine—allergic rhinitis	0.000652	0.00342	CcSEcCtD
Naloxone—TLR4—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000642	0.00739	CbGpPWpGaD
Naloxone—Asthenia—Olopatadine—allergic rhinitis	0.000639	0.00335	CcSEcCtD
Naloxone—Nausea—Cyproheptadine—allergic rhinitis	0.000636	0.00333	CcSEcCtD
Naloxone—CREB1—Validated targets of C-MYC transcriptional repression—SMAD3—allergic rhinitis	0.000633	0.00728	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000627	0.00721	CbGpPWpGaD
Naloxone—Asthenia—Diphenhydramine—allergic rhinitis	0.000625	0.00328	CcSEcCtD
Naloxone—Asthenia—Dimenhydrinate—allergic rhinitis	0.000625	0.00328	CcSEcCtD
Naloxone—Nervous system disorder—Cetirizine—allergic rhinitis	0.000619	0.00324	CcSEcCtD
Naloxone—Nausea—Desloratadine—allergic rhinitis	0.000619	0.00324	CcSEcCtD
Naloxone—Tachycardia—Cetirizine—allergic rhinitis	0.000616	0.00323	CcSEcCtD
Naloxone—Skin disorder—Cetirizine—allergic rhinitis	0.000613	0.00321	CcSEcCtD
Naloxone—OPRD1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000611	0.00703	CbGpPWpGaD
Naloxone—Hyperhidrosis—Cetirizine—allergic rhinitis	0.00061	0.0032	CcSEcCtD
Naloxone—CREB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.00061	0.00702	CbGpPWpGaD
Naloxone—Pulmonary oedema—Betamethasone—allergic rhinitis	0.00061	0.00319	CcSEcCtD
Naloxone—Pulmonary oedema—Dexamethasone—allergic rhinitis	0.00061	0.00319	CcSEcCtD
Naloxone—Diarrhoea—Olopatadine—allergic rhinitis	0.000609	0.00319	CcSEcCtD
Naloxone—Tremor—Montelukast—allergic rhinitis	0.000608	0.00319	CcSEcCtD
Naloxone—Tachycardia—Flunisolide—allergic rhinitis	0.000606	0.00318	CcSEcCtD
Naloxone—CREB1—AP-1 transcription factor network—IL10—allergic rhinitis	0.000605	0.00695	CbGpPWpGaD
Naloxone—Paraesthesia—Loratadine—allergic rhinitis	0.000603	0.00316	CcSEcCtD
Naloxone—Hyperhidrosis—Flunisolide—allergic rhinitis	0.0006	0.00315	CcSEcCtD
Naloxone—ESR1—lung—allergic rhinitis	0.000599	0.0178	CbGeAlD
Naloxone—Agitation—Montelukast—allergic rhinitis	0.000596	0.00312	CcSEcCtD
Naloxone—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.000596	0.00312	CcSEcCtD
Naloxone—Diarrhoea—Diphenhydramine—allergic rhinitis	0.000596	0.00312	CcSEcCtD
Naloxone—CREB1—AP-1 transcription factor network—IL4—allergic rhinitis	0.000588	0.00676	CbGpPWpGaD
Naloxone—TLR4—Immune System—MS4A2—allergic rhinitis	0.000586	0.00674	CbGpPWpGaD
Naloxone—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000579	0.00304	CcSEcCtD
Naloxone—TLR4—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000578	0.00664	CbGpPWpGaD
Naloxone—Pain—Loratadine—allergic rhinitis	0.000574	0.00301	CcSEcCtD
Naloxone—TLR4—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	0.000567	0.00652	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000567	0.00652	CbGpPWpGaD
Naloxone—Paraesthesia—Cetirizine—allergic rhinitis	0.000567	0.00297	CcSEcCtD
Naloxone—Cardiac arrest—Prednisolone—allergic rhinitis	0.000566	0.00297	CcSEcCtD
Naloxone—Vomiting—Olopatadine—allergic rhinitis	0.000566	0.00297	CcSEcCtD
Naloxone—Dyspnoea—Cetirizine—allergic rhinitis	0.000563	0.00295	CcSEcCtD
Naloxone—Convulsion—Montelukast—allergic rhinitis	0.000562	0.00295	CcSEcCtD
Naloxone—Irritability—Hydrocortisone—allergic rhinitis	0.000555	0.00291	CcSEcCtD
Naloxone—Vomiting—Dimenhydrinate—allergic rhinitis	0.000554	0.0029	CcSEcCtD
Naloxone—Vomiting—Diphenhydramine—allergic rhinitis	0.000554	0.0029	CcSEcCtD
Naloxone—Dyspnoea—Flunisolide—allergic rhinitis	0.000554	0.0029	CcSEcCtD
Naloxone—Cardiac arrest—Hydrocortisone—allergic rhinitis	0.000553	0.0029	CcSEcCtD
Naloxone—OPRD1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000549	0.00631	CbGpPWpGaD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000549	0.00287	CcSEcCtD
Naloxone—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000545	0.00286	CcSEcCtD
Naloxone—TLR4—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000543	0.00625	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—IL5—allergic rhinitis	0.000542	0.00623	CbGpPWpGaD
Naloxone—Pain—Cetirizine—allergic rhinitis	0.00054	0.00283	CcSEcCtD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—IL10—allergic rhinitis	0.000538	0.00619	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000537	0.00618	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000536	0.00616	CbGpPWpGaD
Naloxone—Pain—Flunisolide—allergic rhinitis	0.000531	0.00278	CcSEcCtD
Naloxone—Body temperature increased—Loratadine—allergic rhinitis	0.000531	0.00278	CcSEcCtD
Naloxone—Abdominal pain—Loratadine—allergic rhinitis	0.000531	0.00278	CcSEcCtD
Naloxone—Nausea—Olopatadine—allergic rhinitis	0.000529	0.00277	CcSEcCtD
Naloxone—Irritability—Methylprednisolone—allergic rhinitis	0.000522	0.00273	CcSEcCtD
Naloxone—Cardiac arrest—Triamcinolone—allergic rhinitis	0.000521	0.00273	CcSEcCtD
Naloxone—Cardiac arrest—Methylprednisolone—allergic rhinitis	0.00052	0.00272	CcSEcCtD
Naloxone—Nervous system disorder—Montelukast—allergic rhinitis	0.000519	0.00272	CcSEcCtD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.000518	0.00596	CbGpPWpGaD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—SMAD3—allergic rhinitis	0.000518	0.00596	CbGpPWpGaD
Naloxone—Nausea—Diphenhydramine—allergic rhinitis	0.000518	0.00271	CcSEcCtD
Naloxone—Nausea—Dimenhydrinate—allergic rhinitis	0.000518	0.00271	CcSEcCtD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000517	0.00594	CbGpPWpGaD
Naloxone—Skin disorder—Montelukast—allergic rhinitis	0.000514	0.0027	CcSEcCtD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000509	0.00586	CbGpPWpGaD
Naloxone—Abdominal pain—Cetirizine—allergic rhinitis	0.000499	0.00262	CcSEcCtD
Naloxone—Body temperature increased—Cetirizine—allergic rhinitis	0.000499	0.00262	CcSEcCtD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000497	0.00572	CbGpPWpGaD
Naloxone—OPRM1—IL4-mediated signaling events—IL10—allergic rhinitis	0.000492	0.00566	CbGpPWpGaD
Naloxone—Body temperature increased—Flunisolide—allergic rhinitis	0.000491	0.00257	CcSEcCtD
Naloxone—Abdominal pain—Flunisolide—allergic rhinitis	0.000491	0.00257	CcSEcCtD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.00049	0.00563	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—ADIPOQ—allergic rhinitis	0.000488	0.00561	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000486	0.00559	CbGpPWpGaD
Naloxone—TLR4—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000484	0.00557	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL5—allergic rhinitis	0.000482	0.00554	CbGpPWpGaD
Naloxone—Asthenia—Loratadine—allergic rhinitis	0.000482	0.00252	CcSEcCtD
Naloxone—OPRK1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000481	0.00554	CbGpPWpGaD
Naloxone—CREB1—Androgen receptor signaling pathway—SMAD3—allergic rhinitis	0.00048	0.00552	CbGpPWpGaD
Naloxone—OPRM1—IL4-mediated signaling events—IL4—allergic rhinitis	0.000479	0.00551	CbGpPWpGaD
Naloxone—Paraesthesia—Montelukast—allergic rhinitis	0.000475	0.00249	CcSEcCtD
Naloxone—Irritability—Dexamethasone—allergic rhinitis	0.000474	0.00249	CcSEcCtD
Naloxone—Irritability—Betamethasone—allergic rhinitis	0.000474	0.00249	CcSEcCtD
Naloxone—Cardiac arrest—Dexamethasone—allergic rhinitis	0.000473	0.00248	CcSEcCtD
Naloxone—Cardiac arrest—Betamethasone—allergic rhinitis	0.000473	0.00248	CcSEcCtD
Naloxone—ESR1—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.000472	0.00543	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.000469	0.00539	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000465	0.00535	CbGpPWpGaD
Naloxone—Diarrhoea—Loratadine—allergic rhinitis	0.000459	0.00241	CcSEcCtD
Naloxone—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000457	0.0024	CcSEcCtD
Naloxone—Asthenia—Cetirizine—allergic rhinitis	0.000453	0.00237	CcSEcCtD
Naloxone—OPRM1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000453	0.00521	CbGpPWpGaD
Naloxone—Pain—Montelukast—allergic rhinitis	0.000453	0.00237	CcSEcCtD
Naloxone—ABCB1—respiratory system—allergic rhinitis	0.000446	0.0132	CbGeAlD
Naloxone—Asthenia—Flunisolide—allergic rhinitis	0.000445	0.00233	CcSEcCtD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000445	0.00512	CbGpPWpGaD
Naloxone—Diarrhoea—Cetirizine—allergic rhinitis	0.000432	0.00226	CcSEcCtD
Naloxone—Vomiting—Loratadine—allergic rhinitis	0.000427	0.00224	CcSEcCtD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000426	0.0049	CbGpPWpGaD
Naloxone—Diarrhoea—Flunisolide—allergic rhinitis	0.000425	0.00223	CcSEcCtD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00042	0.00483	CbGpPWpGaD
Naloxone—Abdominal pain—Montelukast—allergic rhinitis	0.000419	0.00219	CcSEcCtD
Naloxone—Body temperature increased—Montelukast—allergic rhinitis	0.000419	0.00219	CcSEcCtD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	0.000412	0.00474	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000407	0.00468	CbGpPWpGaD
Naloxone—Sweating—Methylprednisolone—allergic rhinitis	0.000404	0.00212	CcSEcCtD
Naloxone—Vomiting—Cetirizine—allergic rhinitis	0.000402	0.0021	CcSEcCtD
Naloxone—Hallucination—Hydrocortisone—allergic rhinitis	0.0004	0.0021	CcSEcCtD
Naloxone—OPRD1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000399	0.00459	CbGpPWpGaD
Naloxone—Nausea—Loratadine—allergic rhinitis	0.000399	0.00209	CcSEcCtD
Naloxone—ESR1—AP-1 transcription factor network—IL10—allergic rhinitis	0.000396	0.00455	CbGpPWpGaD
Naloxone—Vomiting—Flunisolide—allergic rhinitis	0.000395	0.00207	CcSEcCtD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00039	0.00449	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—SMAD3—allergic rhinitis	0.00039	0.00449	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—IL4—allergic rhinitis	0.000385	0.00443	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000381	0.00439	CbGpPWpGaD
Naloxone—Asthenia—Montelukast—allergic rhinitis	0.00038	0.00199	CcSEcCtD
Naloxone—Hallucination—Methylprednisolone—allergic rhinitis	0.000376	0.00197	CcSEcCtD
Naloxone—Nausea—Cetirizine—allergic rhinitis	0.000375	0.00197	CcSEcCtD
Naloxone—ABCB1—epithelium—allergic rhinitis	0.000372	0.011	CbGeAlD
Naloxone—OPRD1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.00037	0.00426	CbGpPWpGaD
Naloxone—Nausea—Flunisolide—allergic rhinitis	0.000369	0.00193	CcSEcCtD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000368	0.00424	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000363	0.00417	CbGpPWpGaD
Naloxone—Diarrhoea—Montelukast—allergic rhinitis	0.000362	0.0019	CcSEcCtD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.00036	0.00414	CbGpPWpGaD
Naloxone—CREB1—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	0.000357	0.00411	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.000355	0.00409	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—SMAD3—allergic rhinitis	0.000355	0.00408	CbGpPWpGaD
Naloxone—Mental disorder—Hydrocortisone—allergic rhinitis	0.000353	0.00185	CcSEcCtD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—allergic rhinitis	0.000352	0.00405	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—MS4A2—allergic rhinitis	0.000351	0.00404	CbGpPWpGaD
Naloxone—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000351	0.00184	CcSEcCtD
Naloxone—OPRK1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.00035	0.00402	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—ADIPOQ—allergic rhinitis	0.000344	0.00396	CbGpPWpGaD
Naloxone—Angiopathy—Methylprednisolone—allergic rhinitis	0.000343	0.0018	CcSEcCtD
Naloxone—Hallucination—Dexamethasone—allergic rhinitis	0.000342	0.00179	CcSEcCtD
Naloxone—Hallucination—Betamethasone—allergic rhinitis	0.000342	0.00179	CcSEcCtD
Naloxone—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000341	0.00179	CcSEcCtD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—allergic rhinitis	0.000339	0.0039	CbGpPWpGaD
Naloxone—Vomiting—Montelukast—allergic rhinitis	0.000337	0.00176	CcSEcCtD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000334	0.00385	CbGpPWpGaD
Naloxone—Mental disorder—Methylprednisolone—allergic rhinitis	0.000331	0.00174	CcSEcCtD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.00033	0.00379	CbGpPWpGaD
Naloxone—ABCB1—trachea—allergic rhinitis	0.000329	0.00977	CbGeAlD
Naloxone—OPRK1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000324	0.00373	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000323	0.00371	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000323	0.00371	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000319	0.00366	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-G—allergic rhinitis	0.000317	0.00364	CbGpPWpGaD
Naloxone—Nausea—Montelukast—allergic rhinitis	0.000315	0.00165	CcSEcCtD
Naloxone—CREB1—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000314	0.00361	CbGpPWpGaD
Naloxone—Angiopathy—Betamethasone—allergic rhinitis	0.000312	0.00163	CcSEcCtD
Naloxone—Angiopathy—Dexamethasone—allergic rhinitis	0.000312	0.00163	CcSEcCtD
Naloxone—Convulsion—Prednisolone—allergic rhinitis	0.000311	0.00163	CcSEcCtD
Naloxone—Hypertension—Prednisolone—allergic rhinitis	0.00031	0.00162	CcSEcCtD
Naloxone—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000304	0.0035	CbGpPWpGaD
Naloxone—Convulsion—Hydrocortisone—allergic rhinitis	0.000304	0.00159	CcSEcCtD
Naloxone—Hypertension—Hydrocortisone—allergic rhinitis	0.000303	0.00159	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000296	0.00155	CcSEcCtD
Naloxone—OPRM1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000296	0.0034	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.00029	0.00334	CbGpPWpGaD
Naloxone—Convulsion—Triamcinolone—allergic rhinitis	0.000286	0.0015	CcSEcCtD
Naloxone—Tachycardia—Prednisolone—allergic rhinitis	0.000286	0.0015	CcSEcCtD
Naloxone—Convulsion—Methylprednisolone—allergic rhinitis	0.000285	0.00149	CcSEcCtD
Naloxone—Hypertension—Triamcinolone—allergic rhinitis	0.000285	0.00149	CcSEcCtD
Naloxone—Hypertension—Methylprednisolone—allergic rhinitis	0.000284	0.00149	CcSEcCtD
Naloxone—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000283	0.00148	CcSEcCtD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000283	0.00325	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—CD4—allergic rhinitis	0.000281	0.00323	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CCL11—allergic rhinitis	0.00028	0.00323	CbGpPWpGaD
Naloxone—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.00028	0.00147	CcSEcCtD
Naloxone—CREB1—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	0.00028	0.00322	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—NFKB1—allergic rhinitis	0.00028	0.00322	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.00028	0.00322	CbGpPWpGaD
Naloxone—Tachycardia—Hydrocortisone—allergic rhinitis	0.000279	0.00146	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000278	0.00146	CcSEcCtD
Naloxone—Skin disorder—Hydrocortisone—allergic rhinitis	0.000278	0.00146	CcSEcCtD
Naloxone—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000276	0.00145	CcSEcCtD
Naloxone—OPRM1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000274	0.00315	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000273	0.00314	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000271	0.00312	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000268	0.00308	CbGpPWpGaD
Naloxone—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000263	0.00138	CcSEcCtD
Naloxone—Paraesthesia—Prednisolone—allergic rhinitis	0.000263	0.00138	CcSEcCtD
Naloxone—Tachycardia—Triamcinolone—allergic rhinitis	0.000263	0.00138	CcSEcCtD
Naloxone—Tachycardia—Methylprednisolone—allergic rhinitis	0.000262	0.00137	CcSEcCtD
Naloxone—Skin disorder—Methylprednisolone—allergic rhinitis	0.000261	0.00137	CcSEcCtD
Naloxone—CREB1—Glucocorticoid receptor regulatory network—NFKB1—allergic rhinitis	0.000261	0.003	CbGpPWpGaD
Naloxone—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.00026	0.00136	CcSEcCtD
Naloxone—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.00026	0.00299	CbGpPWpGaD
Naloxone—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.00026	0.00136	CcSEcCtD
Naloxone—Convulsion—Dexamethasone—allergic rhinitis	0.000259	0.00136	CcSEcCtD
Naloxone—Convulsion—Betamethasone—allergic rhinitis	0.000259	0.00136	CcSEcCtD
Naloxone—Hypertension—Betamethasone—allergic rhinitis	0.000258	0.00135	CcSEcCtD
Naloxone—Hypertension—Dexamethasone—allergic rhinitis	0.000258	0.00135	CcSEcCtD
Naloxone—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000257	0.00135	CcSEcCtD
Naloxone—TLR4—Immune System—IL5—allergic rhinitis	0.000255	0.00294	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000255	0.00293	CbGpPWpGaD
Naloxone—CREB1—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000253	0.00291	CbGpPWpGaD
Naloxone—CREB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.000251	0.00289	CbGpPWpGaD
Naloxone—Pain—Prednisolone—allergic rhinitis	0.00025	0.00131	CcSEcCtD
Naloxone—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000247	0.00129	CcSEcCtD
Naloxone—CREB1—AP-1 transcription factor network—TGFB1—allergic rhinitis	0.000246	0.00283	CbGpPWpGaD
Naloxone—CREB1—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000246	0.00283	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CCL11—allergic rhinitis	0.000246	0.00283	CbGpPWpGaD
Naloxone—Pain—Hydrocortisone—allergic rhinitis	0.000245	0.00128	CcSEcCtD
Naloxone—ALB—Folate Metabolism—IL4—allergic rhinitis	0.000244	0.0028	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.000242	0.00278	CbGpPWpGaD
Naloxone—Paraesthesia—Triamcinolone—allergic rhinitis	0.000242	0.00127	CcSEcCtD
Naloxone—Paraesthesia—Methylprednisolone—allergic rhinitis	0.000241	0.00126	CcSEcCtD
Naloxone—Dyspnoea—Triamcinolone—allergic rhinitis	0.00024	0.00126	CcSEcCtD
Naloxone—Nervous system disorder—Dexamethasone—allergic rhinitis	0.00024	0.00126	CcSEcCtD
Naloxone—Nervous system disorder—Betamethasone—allergic rhinitis	0.00024	0.00126	CcSEcCtD
Naloxone—Tachycardia—Betamethasone—allergic rhinitis	0.000238	0.00125	CcSEcCtD
Naloxone—Tachycardia—Dexamethasone—allergic rhinitis	0.000238	0.00125	CcSEcCtD
Naloxone—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000238	0.00274	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.000238	0.00273	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	0.000238	0.00273	CbGpPWpGaD
Naloxone—ABCB1—lung—allergic rhinitis	0.000237	0.00702	CbGeAlD
Naloxone—Hyperhidrosis—Betamethasone—allergic rhinitis	0.000236	0.00124	CcSEcCtD
Naloxone—Hyperhidrosis—Dexamethasone—allergic rhinitis	0.000236	0.00124	CcSEcCtD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000235	0.0027	CbGpPWpGaD
Naloxone—CREB1—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000234	0.00269	CbGpPWpGaD
Naloxone—Pain—Triamcinolone—allergic rhinitis	0.00023	0.00121	CcSEcCtD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000228	0.00262	CbGpPWpGaD
Naloxone—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000226	0.00118	CcSEcCtD
Naloxone—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000226	0.00118	CcSEcCtD
Naloxone—CREB1—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000224	0.00258	CbGpPWpGaD
Naloxone—Paraesthesia—Dexamethasone—allergic rhinitis	0.000219	0.00115	CcSEcCtD
Naloxone—Paraesthesia—Betamethasone—allergic rhinitis	0.000219	0.00115	CcSEcCtD
Naloxone—OPRM1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000215	0.00247	CbGpPWpGaD
Naloxone—Body temperature increased—Triamcinolone—allergic rhinitis	0.000213	0.00112	CcSEcCtD
Naloxone—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000212	0.00111	CcSEcCtD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000211	0.00243	CbGpPWpGaD
Naloxone—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000211	0.00111	CcSEcCtD
Naloxone—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000211	0.00111	CcSEcCtD
Naloxone—OPRD1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000209	0.0024	CbGpPWpGaD
Naloxone—Pain—Dexamethasone—allergic rhinitis	0.000209	0.00109	CcSEcCtD
Naloxone—Pain—Betamethasone—allergic rhinitis	0.000209	0.00109	CcSEcCtD
Naloxone—OPRM1—GPCR ligand binding—CCL11—allergic rhinitis	0.000208	0.00239	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—CD4—allergic rhinitis	0.000207	0.00239	CbGpPWpGaD
Naloxone—Asthenia—Hydrocortisone—allergic rhinitis	0.000205	0.00107	CcSEcCtD
Naloxone—CREB1—Immune System—MS4A2—allergic rhinitis	0.000205	0.00235	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—TAC1—allergic rhinitis	0.000204	0.00234	CbGpPWpGaD
Naloxone—CREB1—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000202	0.00232	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000202	0.00232	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000201	0.00232	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000198	0.00228	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	0.000198	0.00228	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	0.000198	0.00228	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-DQB1—allergic rhinitis	0.000198	0.00227	CbGpPWpGaD
Naloxone—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000196	0.00103	CcSEcCtD
Naloxone—ALB—Folate Metabolism—ICAM1—allergic rhinitis	0.000194	0.00223	CbGpPWpGaD
Naloxone—Asthenia—Triamcinolone—allergic rhinitis	0.000193	0.00101	CcSEcCtD
Naloxone—Body temperature increased—Dexamethasone—allergic rhinitis	0.000193	0.00101	CcSEcCtD
Naloxone—Abdominal pain—Dexamethasone—allergic rhinitis	0.000193	0.00101	CcSEcCtD
Naloxone—Abdominal pain—Betamethasone—allergic rhinitis	0.000193	0.00101	CcSEcCtD
Naloxone—Body temperature increased—Betamethasone—allergic rhinitis	0.000193	0.00101	CcSEcCtD
Naloxone—Asthenia—Methylprednisolone—allergic rhinitis	0.000193	0.00101	CcSEcCtD
Naloxone—CREB1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000191	0.00219	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.00019	0.00219	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.00019	0.00218	CbGpPWpGaD
Naloxone—CREB1—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.00019	0.00218	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.000185	0.00213	CbGpPWpGaD
Naloxone—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000184	0.000963	CcSEcCtD
Naloxone—ESR1—Leptin signaling pathway—NFKB1—allergic rhinitis	0.000183	0.00211	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000183	0.00211	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-G—allergic rhinitis	0.000182	0.0021	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CD4—allergic rhinitis	0.000182	0.00209	CbGpPWpGaD
Naloxone—Vomiting—Hydrocortisone—allergic rhinitis	0.000182	0.000953	CcSEcCtD
Naloxone—OPRM1—TCR Signaling Pathway—NFKB1—allergic rhinitis	0.000179	0.00206	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—TAC1—allergic rhinitis	0.000179	0.00205	CbGpPWpGaD
Naloxone—Asthenia—Betamethasone—allergic rhinitis	0.000175	0.000918	CcSEcCtD
Naloxone—Asthenia—Dexamethasone—allergic rhinitis	0.000175	0.000918	CcSEcCtD
Naloxone—Nausea—Prednisolone—allergic rhinitis	0.000174	0.000911	CcSEcCtD
Naloxone—Vomiting—Triamcinolone—allergic rhinitis	0.000171	0.000897	CcSEcCtD
Naloxone—Vomiting—Methylprednisolone—allergic rhinitis	0.000171	0.000895	CcSEcCtD
Naloxone—Nausea—Hydrocortisone—allergic rhinitis	0.00017	0.00089	CcSEcCtD
Naloxone—CREB1—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000169	0.00194	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ADIPOQ—allergic rhinitis	0.000168	0.00193	CbGpPWpGaD
Naloxone—Diarrhoea—Dexamethasone—allergic rhinitis	0.000167	0.000876	CcSEcCtD
Naloxone—Diarrhoea—Betamethasone—allergic rhinitis	0.000167	0.000876	CcSEcCtD
Naloxone—OPRK1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000167	0.00191	CbGpPWpGaD
Naloxone—CREB1—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000166	0.00191	CbGpPWpGaD
Naloxone—ESR1—Regulation of Telomerase—TGFB1—allergic rhinitis	0.000165	0.0019	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000164	0.00189	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—TGFB1—allergic rhinitis	0.000161	0.00186	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.00016	0.00184	CbGpPWpGaD
Naloxone—Nausea—Triamcinolone—allergic rhinitis	0.00016	0.000838	CcSEcCtD
Naloxone—Nausea—Methylprednisolone—allergic rhinitis	0.00016	0.000836	CcSEcCtD
Naloxone—TLR4—Innate Immune System—NFKB1—allergic rhinitis	0.000157	0.0018	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—NFKB1—allergic rhinitis	0.000157	0.0018	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.000156	0.00179	CbGpPWpGaD
Naloxone—Vomiting—Dexamethasone—allergic rhinitis	0.000155	0.000814	CcSEcCtD
Naloxone—Vomiting—Betamethasone—allergic rhinitis	0.000155	0.000814	CcSEcCtD
Naloxone—OPRM1—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000155	0.00178	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000154	0.00177	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—TAC1—allergic rhinitis	0.000151	0.00174	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	0.000151	0.00173	CbGpPWpGaD
Naloxone—CREB1—Adipogenesis—TGFB1—allergic rhinitis	0.00015	0.00173	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000149	0.00172	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000149	0.00171	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—TGFB1—allergic rhinitis	0.000149	0.00171	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000148	0.0017	CbGpPWpGaD
Naloxone—Nausea—Betamethasone—allergic rhinitis	0.000145	0.00076	CcSEcCtD
Naloxone—Nausea—Dexamethasone—allergic rhinitis	0.000145	0.00076	CcSEcCtD
Naloxone—CREB1—Signaling by GPCR—CCL11—allergic rhinitis	0.000144	0.00166	CbGpPWpGaD
Naloxone—TLR4—Immune System—ICAM1—allergic rhinitis	0.000144	0.00166	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCL11—allergic rhinitis	0.000144	0.00166	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000144	0.00165	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000141	0.00162	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000141	0.00162	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000133	0.00152	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000131	0.0015	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.00013	0.0015	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—NFKB1—allergic rhinitis	0.00013	0.0015	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCL11—allergic rhinitis	0.000126	0.00145	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—NFKB1—allergic rhinitis	0.000123	0.00141	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—SMAD3—allergic rhinitis	0.000122	0.0014	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000122	0.0014	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—TAC1—allergic rhinitis	0.000115	0.00132	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000114	0.00131	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000113	0.00129	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000112	0.00129	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-G—allergic rhinitis	0.000111	0.00127	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.00011	0.00127	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.00011	0.00127	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—IL5—allergic rhinitis	0.000107	0.00123	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCL11—allergic rhinitis	0.000107	0.00123	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD4—allergic rhinitis	0.000106	0.00122	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—TAC1—allergic rhinitis	0.000105	0.00121	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000105	0.0012	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—TAC1—allergic rhinitis	0.000105	0.0012	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—TAC1—allergic rhinitis	0.000101	0.00116	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTGDR2—allergic rhinitis	9.84e-05	0.00113	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL5—allergic rhinitis	9.75e-05	0.00112	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	9.74e-05	0.00112	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL5—allergic rhinitis	9.72e-05	0.00112	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—NFKB1—allergic rhinitis	9.6e-05	0.0011	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—IL5—allergic rhinitis	9.39e-05	0.00108	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—TAC1—allergic rhinitis	9.17e-05	0.00105	CbGpPWpGaD
Naloxone—TLR4—Immune System—NFKB1—allergic rhinitis	9.13e-05	0.00105	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL5—allergic rhinitis	8.91e-05	0.00102	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CYSLTR1—allergic rhinitis	8.83e-05	0.00102	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	8.8e-05	0.00101	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—TGFB1—allergic rhinitis	8.76e-05	0.00101	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	8.68e-05	0.000998	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TAC1—allergic rhinitis	8.53e-05	0.000981	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCL11—allergic rhinitis	8.53e-05	0.000981	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL5—allergic rhinitis	8.52e-05	0.00098	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCL11—allergic rhinitis	8.5e-05	0.000978	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—SMAD3—allergic rhinitis	8.48e-05	0.000976	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	8.35e-05	0.00096	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTGDR2—allergic rhinitis	8.31e-05	0.000956	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ICAM1—allergic rhinitis	8.3e-05	0.000955	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL5—allergic rhinitis	7.93e-05	0.000912	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	7.75e-05	0.000892	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TAC1—allergic rhinitis	7.75e-05	0.000891	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CYSLTR1—allergic rhinitis	7.72e-05	0.000888	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCL11—allergic rhinitis	7.45e-05	0.000857	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTGDR2—allergic rhinitis	7.37e-05	0.000848	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	7.23e-05	0.000832	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL5—allergic rhinitis	7.2e-05	0.000828	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DQB1—allergic rhinitis	6.9e-05	0.000793	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL5—allergic rhinitis	6.72e-05	0.000773	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CYSLTR1—allergic rhinitis	6.52e-05	0.00075	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD4—allergic rhinitis	6.35e-05	0.000731	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCL11—allergic rhinitis	6.3e-05	0.000725	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—NFKB1—allergic rhinitis	6.2e-05	0.000713	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TAC1—allergic rhinitis	6.2e-05	0.000713	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TAC1—allergic rhinitis	6.18e-05	0.00071	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD4—allergic rhinitis	6.1e-05	0.000702	CbGpPWpGaD
Naloxone—CREB1—Disease—SMAD3—allergic rhinitis	5.79e-05	0.000666	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CYSLTR1—allergic rhinitis	5.78e-05	0.000665	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL5—allergic rhinitis	5.76e-05	0.000663	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL5—allergic rhinitis	5.74e-05	0.00066	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCL11—allergic rhinitis	5.59e-05	0.000642	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—NFKB1—allergic rhinitis	5.47e-05	0.000629	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TAC1—allergic rhinitis	5.42e-05	0.000623	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—NFKB1—allergic rhinitis	5.26e-05	0.000604	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—allergic rhinitis	5.16e-05	0.000594	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL5—allergic rhinitis	5.04e-05	0.000579	CbGpPWpGaD
Naloxone—CREB1—Immune System—ICAM1—allergic rhinitis	5.03e-05	0.000579	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.59e-05	0.000528	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TAC1—allergic rhinitis	4.58e-05	0.000526	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL5—allergic rhinitis	4.26e-05	0.000489	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—SMAD3—allergic rhinitis	4.08e-05	0.00047	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TAC1—allergic rhinitis	4.06e-05	0.000467	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SMAD3—allergic rhinitis	4.05e-05	0.000466	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SMAD3—allergic rhinitis	4.04e-05	0.000465	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.89e-05	0.000447	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.83e-05	0.00044	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL5—allergic rhinitis	3.77e-05	0.000434	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD4—allergic rhinitis	3.7e-05	0.000426	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SMAD3—allergic rhinitis	3.54e-05	0.000408	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—allergic rhinitis	3.42e-05	0.000393	CbGpPWpGaD
Naloxone—CREB1—Immune System—NFKB1—allergic rhinitis	3.19e-05	0.000367	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SMAD3—allergic rhinitis	3e-05	0.000344	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SMAD3—allergic rhinitis	2.66e-05	0.000305	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—allergic rhinitis	2.45e-05	0.000282	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NFKB1—allergic rhinitis	2.06e-05	0.000237	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NFKB1—allergic rhinitis	2.05e-05	0.000236	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—allergic rhinitis	2e-05	0.00023	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NFKB1—allergic rhinitis	1.8e-05	0.000207	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—allergic rhinitis	1.72e-05	0.000197	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—allergic rhinitis	1.71e-05	0.000197	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NFKB1—allergic rhinitis	1.52e-05	0.000175	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—allergic rhinitis	1.5e-05	0.000173	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NFKB1—allergic rhinitis	1.35e-05	0.000155	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—allergic rhinitis	1.27e-05	0.000146	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—allergic rhinitis	1.12e-05	0.000129	CbGpPWpGaD
